WORLDSymposium™ has reviewed and approved this Satellite Symposium as appropriate for presentation as an independent educational activity held in conjunction with WORLDSymposium 2023. This Satellite Symposium is not of the official WORLDSymposium program, and WORLDSymposium does not approve or endorse any commercial products or services discussed during the Satellite Symposium or offered for sale by the corporate supporter of the Satellite Symposium. This Satellite Symposium is not approved for CME by WORLDSymposium. This Satellite Symposium is approved for CME credit by Med Learning Group.
Eligibility: Registration for WORLDSympoisum 2023 and an official name badge are required to attend this satellite symposium
Saturday, February 25, 2023
5:45 – 6:15 AM Breakfast
6:15 – 7:15 AM Symposium
Hilton Orlando
6001 Destination Parkway
Orlando, FL 32819
Meeting room: Orlando I
PROGRAM FEATURES
-
- Online personalized quality-improvement poster-generation portal
- Downloadable whiteboard animation
FACULTY
![]() |
Virginia Kimonis, MD, MRCP Professor University of California, Irvine, Children’s Hospital of Orange County University of California Irvine, Children’s Hospital of Orange County Irvine, CA |
LEARNING OBJECTIVES
- Relate the pathophysiology of FD to the development of cardiac and renal manifestations
- Develop strategies for identifying, monitoring, and addressing risk factors impacting long-term cardiac, renal, and neurological progression and clinical outcomes in order to implement evidence-based long-term FD management given these considerations
TARGET AUDIENCE
This educational activity is specifically designed for US-based healthcare professionals involved in the management of patients with Fabry disease, including nephrologists, cardiologists, endocrinologists, medical geneticists, and other healthcare professionals.
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live virtual activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with Fabry disease.
CNE Credits: 1.0 ANCC Contact Hour.
CNE Accreditation Statement: Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
commercial product or device not yet approved for use in the United States.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at [email protected].
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (ie, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]